Image-Guided Radiation Therapy Market to Grow with a CAGR of 5.37% through 2029
The growing body of clinical evidence supporting the efficacy and safety
of IGRT in cancer treatment are the major drivers for the Global Image-Guided
Radiation Therapy Market
According to TechSci Research report, “Image-Guided
Radiation Therapy Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the Global Image-Guided Radiation Therapy Market was valued at USD 1.82 billion in 2023 and will see an impressive growth in the
forecast period at a CAGR of 5.37% to 2029. This can be attributed to the awareness among
individuals regarding Image-Guided Radiation Therapy which has led to a
favorable market. The geriatric population experiences a higher
incidence of cancer compared to younger age groups. As individuals age, they
are at greater risk of developing cancer due to factors such as accumulated
environmental exposures, lifestyle factors, and age-related changes in cellular
function. The rising prevalence of cancer among older adults drives the demand
for advanced treatment modalities like IGRT, which offer precise tumor
targeting and improved treatment outcomes.
Cancer management in older adults can be challenging
due to age-related comorbidities, decreased functional status, and
physiological changes that may impact treatment tolerance and response. IGRT
provides a non-invasive and targeted approach to radiation therapy, allowing
clinicians to deliver precise radiation doses while minimizing damage to
surrounding healthy tissues. The advanced imaging capabilities of IGRT enable
clinicians to tailor treatment plans to the individual needs and
characteristics of older patients, optimizing treatment outcomes and reducing
the risk of treatment-related complications. Older adults may prefer minimally
invasive treatment options that offer fewer side effects and shorter recovery
times compared to surgery or traditional radiation therapy techniques. IGRT
meets this demand by offering a non-invasive and image-guided approach to
radiation therapy, allowing for precise tumor targeting and reduced radiation
exposure to healthy tissues. The minimally invasive nature of IGRT makes it
well-suited for older adults who may have age-related vulnerabilities or health
concerns that make them less tolerant of invasive treatment modalities.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "Global Image-Guided Radiation Therapy Market”
In December 2023, The Central Luzon
Integrated Oncology Center (CLIOC) aims to streamline the cancer patient care
journey and offer advanced treatments, especially considering the
disproportionate number of cancer patients in the Philippines and limited
accessibility to treatment. At the Mother Teresa of Calcutta Medical Center
(MTCMC), CLIOC has introduced Radixact, the most advanced radiation therapy
machine available in the country, enhancing the center's capabilities in
delivering cutting-edge cancer care.
IGRT systems are technologically
advanced and complex, involving multiple components such as imaging devices,
treatment planning software, and radiation delivery systems. The complexity of
IGRT technology increases the risk of technical errors, equipment malfunctions,
and user errors, which can compromise patient safety and treatment efficacy if
not adequately managed. IGRT involves the use of ionizing radiation to deliver
targeted doses of radiation to cancerous tumours. While IGRT aims to minimize
radiation exposure to surrounding healthy tissues, there is still a risk of
radiation-related side effects and long-term toxicities if treatment parameters
are not optimized or if patient positioning and alignment are not accurate.
The Global Image-Guided Radiation Therapy Market is
segmented into Product, Application, Procedure, regional distribution, and
company.
Based on its Product, Global Image-Guided Radiation
Therapy Market is segmented into 4D RT, LINAC, MRI-guided radiotherapy, Portal
CT Imaging. Portal CT imaging, also known as portal imaging, is a technique used in
radiation therapy to verify the position of the patient and ensure accurate
delivery of radiation to the target area. It involves taking X-ray images of
the treatment field just before or during radiation therapy sessions. Before each
radiation therapy session, the patient is positioned on the treatment table
according to the treatment plan previously developed by the radiation
oncologist. The patient's position is critical to ensure that the radiation
beams are accurately targeted at the tumor while minimizing exposure to healthy
surrounding tissues. Once the patient is positioned, a specialized X-ray
imaging device, typically mounted on the treatment machine, is used to capture
images of the treatment area. The X-ray beams pass through the patient's body
and are detected by a digital imaging system, which generates high-resolution
X-ray images of the treatment field.
Based on region, North America is dominating the
market. The reimbursement landscape in North America, particularly in the United
States, supports the adoption of IGRT technologies by providing favorable
reimbursement rates for radiation therapy procedures. Reimbursement policies
from government payers, private insurance companies, and Medicare/Medicaid
programs incentivize healthcare providers to invest in advanced radiation
therapy equipment and techniques, further solidifying North America's position
as a key market for IGRT. North America fosters a culture of clinical research,
collaboration, and interdisciplinary care within the healthcare community.
Collaborative efforts between academic institutions, research organizations,
industry partners, and healthcare providers drive clinical trials, outcomes
research, and the development of evidence-based practices in radiation
oncology, including the utilization of IGRT technologies. Patients in North
America are increasingly aware of advanced treatment options for cancer care
and often seek out facilities that offer cutting-edge technologies like IGRT.
Patient demand for personalized, effective, and minimally invasive treatment
approaches fuels the adoption of IGRT in the region, prompting healthcare
providers to invest in state-of-the-art equipment and infrastructure to meet
patient needs and preferences.
Major companies operating in Global Image-Guided
Radiation Therapy Market are:
- Siemens Healthineers AG
- Viewray Technologies Inc.
- Varian Medical Systems
- Toshiba Corporation
- General Electric Healthcare Company
- Accuray Inc.
- Becton, Dickinson, and Company
- Vision RT Ltd
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The Image-Guided Radiation Therapy (IGRT) Market is
positioned for sustained expansion and innovation as healthcare providers
endeavor to enhance treatment efficacy, elevate patient satisfaction, and
propel advancements in radiation oncology through the integration of
state-of-the-art imaging and treatment delivery technologies. By embracing
principles of innovation, collaboration, and patient-centric care, the IGRT
market is set to deliver substantial contributions to combating cancer and
enhancing patient well-being on a global scale.," said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based Global management
consulting firm.
“Image-Guided Radiation Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2019-2029 Segmented By Product (4D RT, LINAC, MRI-guided
radiotherapy, Portal CT Imaging), By Procedure (IMRT, Stereotactic, Particle),
By Application (Neck, Prostate, Breast cancer), By Region, and By Competition”, has evaluated
the future growth potential of Global Image-Guided Radiation Therapy Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Image-Guided
Radiation Therapy Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com